Director, Quality
Precede Biosciences
Summary
Precede Biosciences is seeking a detail-oriented and experienced Quality Assurance professional to support and maintain our Quality Management System (QMS) in a regulated medical device and clinical laboratory environment. The ideal candidate will have hands-on experience with ISO 13485, ISO 14971, IEC 62304, GCP, CLIA, and CAP regulatory requirements, including software quality and validation.
Job description
The Opportunity
Precede Biosciences is seeking a detail-oriented and experienced Quality Assurance professional to support and maintain our Quality Management System (QMS) in a regulated medical device and clinical laboratory environment. The ideal candidate will have hands-on experience with ISO 13485, ISO 14971, IEC 62304, GCP, CLIA, and CAP regulatory requirements, including software quality and validation.
Responsibilities
- Maintain, implement, and continuously improve the QMS in accordance with FDA, ISO, and applicable regulations.
- Manage and maintain controlled quality systems and documentation such as nonconformances, complaints, CAPA, and OOS.
- Analyze quality trends, recurring issues, audit findings, and process performance indicators.
- Support design and development controls, design reviews, design verification and validation, and design history documentation.
- Apply risk management principles to product development, manufacturing, software, and quality processes.
- Establish quality metrics and identify opportunities for process improvement.
- Lead risk-based software validation activities in accordance with IEC 62304, including software classification (Class A/B/C), SOUP identification and risk assessment, and lifecycle documentation from software development plan through release.
- Define/support/execute software verification and validation protocols for diagnostic algorithms, laboratory information systems, bioinformatics pipelines, and quality management software, including unit, integration, and system-level testing with documented acceptance criteria and traceability to software requirements.
- Evaluate and document software changes and releases under change control, assessing impact on existing validation status and determining whether revalidation or bridging studies are required.
- Manage computerized systems validation (CSV) in compliance with 21 CFR Part 11 for electronic records and signatures, including validation of eQMS, LIMS, and other regulated software platforms.
- Lead supplier qualification, supplier audits, and ongoing supplier performance monitoring.
- Plan, conduct, and support internal quality audits and compliance assessments.
- Lead external audits, regulatory inspections, customer audits, and accreditation assessments by maintaining audit-ready status.
- Develop and deliver quality and compliance training for employees and relevant stakeholders.
- Partner with functional areas to ensure personnel are trained in applicable procedures, and competencies are completed in a timely manner.
Qualifications
- Bachelor's degree in relevant disciplines such as life sciences, biomedical engineering, or related field.
- At least 10 years of experience in quality assurance, quality systems, regulatory compliance, medical devices, diagnostics, clinical laboratories, or related regulated industry.
- Demonstrated working knowledge of ISO 13485, ISO 14971, IEC 62304, FDA, and laboratory requirements.
- Hands-on experience with software quality assurance and computerized systems.
- Experience with document control, change control, risk management, nonconformances, CAPA, and audit readiness.
- Strong analytical, organizational, technical writing, and problem-solving skills.
- Ability to work collaboratively across technical and operational teams and manage multiple priorities.
Preferred Qualifications
- Experience supporting in vitro diagnostic (IVD) medical devices, diagnostic software, laboratory information systems, or laboratory-developed tests.
- Familiarity with FDA 21 CFR Part 820, including the Quality Management System Regulation (QMSR), and applicable electronic records requirements under 21 CFR Part 11.
- Experience with CLIA/CAP inspections, accreditation preparation, and remediation of inspection findings.
- Experience with laboratory quality control, proficiency testing, method verification or validation, and quality assessment programs.
- Experience with electronic QMS (eQMS), document management, defect tracking, and requirements or test management systems.
- Internal auditor training or certification in ISO 13485 or a related quality standard.
- Experience working in a regulated environment that combines medical device software development and clinical laboratory operations.
Requirements
- Bachelor's degree in relevant disciplines such as life sciences, biomedical engineering, or related field
- At least 10 years of experience in quality assurance, quality systems, regulatory compliance, medical devices, diagnostics, clinical laboratories, or related regulated industry
- Demonstrated working knowledge of ISO 13485, ISO 14971, IEC 62304, FDA, and laboratory requirements
- Hands-on experience with software quality assurance and computerized systems
- Experience with document control, change control, risk management, nonconformances, CAPA, and audit readiness
- Strong analytical, organizational, technical writing, and problem-solving skills
- Ability to work collaboratively across technical and operational teams and manage multiple priorities
Benefits
- Performance Bonuses
- Equity Participation
- Comprehensive Health Benefits
Company overview
Precede Biosciences is a pioneering biotechnology company that has developed a first-in-class liquid biopsy platform to revolutionize precision medicine. Founded in 2021 and headquartered in Boston, Massachusetts, the company emerged from stealth in 2023 with $57 million in Series A funding from prominent investors including 5AM Ventures and Lilly Asia Ventures. Precede's breakthrough technology enables comprehensive epigenomic profiling from just 1mL of plasma, simultaneously analyzing circulating chromatin and the DNA methylome to reveal disease-defining transcriptional biology. This unique platform provides unprecedented resolution into the dynamic activity of individual genes and pathways in diseased tissues, offering capabilities beyond conventional genomic liquid biopsy technologies that focus primarily on somatic mutations. The company's approach is particularly valuable for drug development partnerships, enabling the identification of biology associated with treatment response and resistance, as well as novel therapeutic targets. Precede is actively developing blood-based clinical tests to advance precision use of cancer medicines in clinical practice, addressing the limitations of invasive tissue-based diagnostics. With applications spanning oncology, auto-immunity, and other conditions, Precede Biosciences aims to improve drug development success rates and build a future where every patient can receive minimally invasive, biology-informed diagnosis and therapy.